34
The potassium-competitive acid blocker vonoprazan provides faster and stronger gastric acid inhibition than the proton pump inhibitor lansoprazole. This is evident from a randomized controlled patient study by Laine et al. The findings were recently published in the American Journal of Gastroenterology.
More information is only accessible to subscribers who are authorized to prescribe.
Login
NB: To see all the information you need an account to log in. Are you already logged in? Then you do not have sufficient rights to view this information. Do you want to adjust your account? Then click here
Also interesting: Many patients use an antacid for too long
Bron:
Laine L, Sharma P, Mulford DJ, et al. Pharmacodynamics and Pharmacokinetics of the Potassium-Competitive Acid Blocker Vonoprazan and the Proton Pump Inhibitor Lansoprazole in US Subjects. Am J Gastroenterol. 2022;117:1158-61.